Meet Our Scientific Leaders: A/Prof. Louise Cheng

Share this:

We want to introduce you to A/Prof. Louise Cheng, member of Phenomics Australia’s Scientific Director’s team and Co-head of the Phenomics Australia Australian Drosophila Transgenic Facility (ADTF) node at Peter MacCallum Cancer Centre.

Meet Louise:

A/Prof Louise Cheng is a group leader at the Peter MacCallum Cancer Centre and at the Department of Anatomy and Physiology at the University of Melbourne.

She has been an ARC Future Fellow (2019-2022), and was awarded the Marshall and Warren NHMRC Research Excellence award (2024). She leads the cancer cachexia program (CaXI) at the Peter MacCallum Cancer Center. A/Prof Cheng did her PhD at Kings College London and was trained in Prof Alex Gould’s lab at the National Institute for Medical Research, UK. The Cheng lab uses the model organism Drosophila to address fundamental questions in biology such as how differentiation is maintained in post-mitotic neurons and how inter-organ communication plays a role in cancer cachexia.

ADTF team at PeterMac

The ADTF boasts cutting-edge microinjection equipment, ensuring the consistent and efficient production of a diverse array of transgenic Drosophila strains. This state-of-the-art facility offers Australian research centers significant advantages, capitalizing on economies of scale and elevating the overall productivity of their researchers.

ACDT actively fosters collaboration among local researchers, augmenting their appeal to international counterparts. By substantially reducing entry costs and technical barriers associated with Drosophila research, it facilitates a seamless transition for investigators currently immersed in other experimental systems. Moreover, the facility contributes to the expansion of Australia’s research skill set, creating valuable employment and training opportunities in the process.

With an established track record and reputation for excellence, Phenomics Australia In Vivo Genome Engineering and Disease Modelling team uses techniques such as CRISPR-mediated mutagenesis, classical gene targeting, and transgenesis to create optimal tools for your research delivering a comprehensive service in genome modification. To meet the high demand for this platform, Phenomics Australia offers genome editing services through five nodes across Australia, operating at MonashANUONJCRISAHMRI and PeterMac.

Phenomics Australia Feedback Form

Phenomics Australia (formerly the Australian Phenomics Network, APN) offers consolidated infrastructure and expertise supporting genomic medicine and biomedical research from discovery through into early clinical development and evaluation.

Phenomics Australia is a founding capability enabled by the National Collaborative Research Infrastructure Strategy (NCRIS). We would love to hear from you!

Please feel free to provide any ideas or general comments you might have so that we can further improve how Phenomics Australia can support you.

Phenomics Australia PHENOMENA News Contribution

Have you recently had a publication accepted? Do you want to tell us about a grant you have received? Or maybe you have just been recently in the news? You can complete this form to tell us about your latest research developments.

Information provided will be used to inform press releases, website stories, social media content and more. This form is being used to capture everything that is happening at Phenomics Australia, which can then be used as part of our outreach and communications.

Once you have completed the form, the Communications and Outreach Coordinator will then be in contact with you.

Thanks.

Make an Enquiry

_Get in touch to discuss how we can help with your research.